Risk factors for low BMD in patients with Crohn's disease and ulcerative colitis

Risk factors for low BMD in patients with Crohn's disease and ulcerative colitis

Εμφάνιση άλλων εκδόσεων (1)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	McCrudden, R, Javaid, M, Shore, S, Stroud, M, Taylor, P, Fine, DR, Cooper, C, Arden, N
Μορφή:	Conference item
Έκδοση:	2001

Παρόμοια τεκμήρια

Risk factors for low BMD in patients with Crohn's disease and ulcerative colitis.
ανά: McCrudden, R, κ.ά.
Έκδοση: (2000)

Evaluation of calcaneal ultrasound and DXA to assess the risk of corticosteroid osteoporosis
ανά: Javaid, M, κ.ά.
Έκδοση: (2001)

Evaluation of calcaneal ultrasound and DXA to assess the risk of corticosteroid osteoporosis.
ανά: Javaid, M, κ.ά.
Έκδοση: (2000)

Comparison of calcaneal ultrasound and DXA to assess the risk of corticosteroid-induced osteoporosis: a cross-sectional study.
ανά: Javaid, M, κ.ά.
Έκδοση: (2001)

Body mass index and bone mineral density by dexa in inflammatory bowel disease
ανά: Stroud, M, κ.ά.
Έκδοση: (2001)

Nutritional status and osteoporosis in outpatients with Crohn's disease
ανά: Stroud, M, κ.ά.
Έκδοση: (1999)

Predictors of osteoporosis in patients with inflammatory disease - A cross sectional study
ανά: Westlake, S, κ.ά.
Έκδοση: (2005)

Risk Factors for Relapse and Recurrence of Ulcerative Colitis and Crohn’s Disease
ανά: Paul Rutgeerts
Έκδοση: (1993-01-01)

Immune complexes in ulcerative colitis and Crohn's disease.
ανά: Hodgson, H, κ.ά.
Έκδοση: (1977)

Aetiology and pathogenesis of ulcerative colitis and Crohn's disease.
ανά: Jewell, D
Έκδοση: (1989)

Corticosteroids for the management of ulcerative colitis and Crohn's disease.
ανά: Jewell, D
Έκδοση: (1989)

Clq metabolism in ulcerative colitis and Crohn's disease.
ανά: Potter, B, κ.ά.
Έκδοση: (1979)

Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
ανά: A. E. Dorofeyev, κ.ά.
Έκδοση: (2013-01-01)

Review of pregnancy in Crohn’s disease and ulcerative colitis
ανά: Robyn Laube, κ.ά.
Έκδοση: (2021-05-01)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
ανά: Travis, S
Έκδοση: (1997)

Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease
ανά: N A Danilova, κ.ά.
Έκδοση: (2019-04-01)

Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
ανά: Potter, B, κ.ά.
Έκδοση: (1980)

C3 metabolism in ulcerative colitis and Crohn's disease.
ανά: Hodgson, H, κ.ά.
Έκδοση: (1977)

Circulating immune complexes in ulcerative colitis and Crohn's disease.
ανά: Jewell, D, κ.ά.
Έκδοση: (1972)

Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis.
ανά: Rhodes, J, κ.ά.
Έκδοση: (1983)

Why Distinguish between Ulcerative Colitis and Crohn’s Disease?
ανά: Daniel Rachmilewitz
Έκδοση: (1989-01-01)

CLINICOPATHOLOGIC PECULIARITIES OF NONSPECIFIC ULCERATIVE COLITIS AND CROHN'S DISEASE
ανά: S. D. Strelkova, κ.ά.
Έκδοση: (2021-07-01)

Two for One: Coexisting Ulcerative Colitis and Crohn’s Disease
ανά: Grant I Chen, κ.ά.
Έκδοση: (2002-01-01)

Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
ανά: Da-Yeon Kang, κ.ά.
Έκδοση: (2023-11-01)

Expressing the differences between Crohn disease and ulcerative colitis.
Έκδοση: (2005-08-01)

Expressing the differences between Crohn disease and ulcerative colitis.
ανά: Cisca Wijmenga
Έκδοση: (2005-08-01)

Low meat intake is associated with a reduction in BMD: The Hertfordshire cohort study
ανά: Mitchell, A, κ.ά.
Έκδοση: (2006)

Fatty acid composition and function of mononuclear cells in Crohn's disease
ανά: Trebble, T, κ.ά.
Έκδοση: (2003)

Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.
ανά: Anderson, C, κ.ά.
Έκδοση: (2009)

Similar Risk of Depression and Anxiety Following Surgery or Hospitalization for Crohn's Disease and Ulcerative Colitis
ανά: Ananthakrishnan, Ashwin N., κ.ά.
Έκδοση: (2014)

Ulcerative colitis and Crohn's disease--susceptibility genes and clinical patterns.
ανά: Jewell, D
Έκδοση: (1998)

Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
ανά: Rhodes, J, κ.ά.
Έκδοση: (1982)

Imaging findings of thoracic manifestations of Crohn’s disease and ulcerative colitis
ανά: Quentin Cassius De Linval, κ.ά.
Έκδοση: (2024-08-01)

Evaluation of Selenium Concentrations in Patients with Crohn’s Disease and Ulcerative Colitis
ανά: Michał Chalcarz, κ.ά.
Έκδοση: (2024-09-01)

Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease
ανά: Reza Yarani, κ.ά.
Έκδοση: (2022-06-01)

ULCERATIVE COLITIS AND CROHN DISEASE IN CHILDREN – AN EVOLVING PROBLEM IN ROMANIA
ανά: Cristina Becheanu, κ.ά.
Έκδοση: (2014-06-01)

Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
ανά: Jagadesan Sankarasubramanian, κ.ά.
Έκδοση: (2020-11-01)

A comparison of diverticulitis in Crohn's disease versus ulcerative colitis
ανά: Alana Persaud, κ.ά.
Έκδοση: (2019-12-01)

Smart Model to Distinguish Crohn’s Disease from Ulcerative Colitis
ανά: Anna Kasperczuk, κ.ά.
Έκδοση: (2019-04-01)

Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease.
ανά: Trebble, T, κ.ά.
Έκδοση: (2004)